LI
Luca Issi RBC Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ionis Pharmaceuticals
IONS
$9.46B
| $59.35 | $80 |
35%
upside
| Outperform | 15 hours ago |
|
2
argenx
ARGX
$44.9B
| $733.66 | $850 |
16%
upside
| Outperform | 10 days ago |
|
3
Regenxbio
RGNX
$476M
| $9.42 | $17 |
80%
upside
| Outperform | 27 days ago |
|
4
Intellia Therapeutics
NTLA
$1.25B
| $11.62 | $21 |
81%
upside
| Outperform | 27 days ago |
|
5
Ascendis Pharma
ASND
$12B
| $198.13 | $230 |
16%
upside
| Outperform | 27 days ago |
|
6
Arrowhead Research
ARWR
$3.87B
| $28 | $38 |
36%
upside
| Outperform | 27 days ago |
|
7
CRISPR Therapeutics
CRSP
$4.8B
| $52.74 | $42 |
20%
downside
| Sector Perform | 1 month ago |
|
8
Fulcrum Therapeutics
FULC
$372M
| $6.88 | $5 |
27%
downside
| Sector Perform | 1 month ago |
|
9
Dyne Therapeutics
DYN
$1.88B
| $13.24 | $23 |
74%
upside
| Outperform | 1 month ago |
|
10
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $18 |
37%
downside
| Sector Perform | 3 months ago |
|
11
Moderna
MRNA
$9.45B
| $24.28 | $28 |
15%
upside
| Sector Perform | 4 months ago |
|
12
Lexeo Therapeutics
LXEO
$268M
| $4.97 | $20 |
302%
upside
| Outperform | 5 months ago |
|
13
Alnylam Pharmaceuticals
ALNY
$59.4B
| $453.54 | $330 |
27%
downside
| Outperform | 5 months ago |
|
14
Korro Bio
KRRO
$264M
| $28.09 | $95 |
238%
upside
| Outperform | 5 months ago |
|
15
Ocular Therapeutix
OCUL
$2.21B
| $12.70 | $17 |
34%
upside
| Outperform | 5 months ago |
|
16
MeiraGTx Holdings
MGTX
$621M
| $7.72 | $13 |
68%
upside
| Outperform | 5 months ago |
|
17
4D Molecular Therapeutics
FDMT
$309M
| $6.61 | $35 |
430%
upside
| Outperform | 6 months ago |
|
18
Beam Therapeutics
BEAM
$1.88B
| $18.54 | $26 |
40%
upside
| Sector Perform | 6 months ago |
|
19
BioMarin Pharmaceuticals
BMRN
$10.9B
| $56.75 | $70 |
23%
upside
| Sector Perform | 6 months ago |
|
20
uniQure
QURE
$973M
| $17.73 | $24 |
35%
upside
| Outperform | 7 months ago |
|
21
Schlumberger
SLB
$53.7B
| $36.01 | $57 |
58%
upside
| Outperform | 7 months ago |
|
22
Avidity Biosciences
RNA
$6.24B
| $48.47 | $67 |
38%
upside
| Outperform | 7 months ago |
|
23
Ultragenyx Pharmaceutical
RARE
$3.01B
| $31.28 | $77 |
146%
upside
| Outperform | 10 months ago |
|
24
Wave Life Sciences
WVE
$1.3B
| $8.18 | $15 |
83%
upside
| Sector Perform | 10 months ago |
|